Hosoya, Tatsuo
Sano, Takafumi
Sasaki, Tomomitsu
Fushimi, Masahiko
Ohashi, Tetsuo
Article History
Received: 16 September 2019
Accepted: 3 November 2019
First Online: 3 December 2019
Compliance with ethical standards
:
: The study protocol and informed consent document were reviewed and approved by an institutional review board (Shinagawa East One Medical Clinic, Tokyo, Japan; Nakameguro Atlas Clinic, Tokyo, Japan; Asai Dermatology Clinic, Kanagawa, Japan). Informed consent was obtained from all individual participants included in the study. The tests were conducted in compliance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards, good clinical practice guidelines, and other regulatory requirements to be applied. The information of this study was registered with ClinicalTrials.gov (ClinicalTrials.gov number: NCT02416167).
: Fuji Yakuhin Co., Ltd. (Fuji) the manufacturer of dotinurad sponsored this study. TH was advisor to Fuji regarding this study and received consultant and manuscript fees. The other authors were employees of Fuji.